Leprosy Clinical Trial
Official title:
Clinic-Epidemiological Evaluation of Ulcers in Leprosy Patients and the Use of Low Level Laser Therapy: a Randomized Clinical Trial
Neuropathic ulcers are common sequelae of leprosy. The objectives of this study are to analyze the clinic-epidemiological characteristics of patients attended at one specialized dressing service from a leprosy-endemic region of the Brazilian Amazon and to evaluate the effect of Low Level Laser Therapy on wound healing of these patients.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03302897 -
Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers
|
Phase 1 | |
| Recruiting |
NCT05243654 -
Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy
|
Phase 2 | |
| Completed |
NCT05091216 -
The Effects of Traditional Chinese Medicine Mouthwash Solutions on the Oral Health of Leprosy Patients
|
N/A | |
| Recruiting |
NCT06222372 -
Novel Interventions and Diagnostic Tests for Leprosy
|
N/A | |
| Terminated |
NCT03084614 -
CD8 Reactivity to Microorganisms in Blood and Breast Milk
|
||
| Recruiting |
NCT05597280 -
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
|
Phase 3 | |
| Terminated |
NCT01751503 -
Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer
|
N/A | |
| Active, not recruiting |
NCT03324035 -
Treatment of Neuropathic Pain in Leprosy
|
Phase 3 | |
| Completed |
NCT03683745 -
Integrated Mapping of Skin-presenting Neglected Tropical Diseases in Liberia
|
||
| Recruiting |
NCT02550080 -
Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
|
Phase 4 | |
| Completed |
NCT02484469 -
Impact of the Virtual Human Project on Team-based Learning: A Randomized-controlled Trial
|
N/A | |
| Completed |
NCT01165840 -
Effect of Weight and/or Obesity on Dapsone Drug Concentrations
|
Phase 4 | |
| Completed |
NCT00919542 -
Ciclosporin in the Management of New Erythema Nodosum Leprosum
|
Phase 2 | |
| Completed |
NCT05406479 -
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)
|
Phase 2 | |
| Recruiting |
NCT03807362 -
CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum
|
Phase 2 | |
| Completed |
NCT01006759 -
Prevention of Disability: Proposal for a Guidance Manual for Leprosy Patients
|
Phase 1 | |
| Completed |
NCT03662022 -
Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
|
Phase 3 | |
| Completed |
NCT01920750 -
Leprosy Skin Test Antigens Phase 1
|
Phase 1 | |
| Recruiting |
NCT06416033 -
Serum Irisin Level In Leprosy Patients
|
||
| Not yet recruiting |
NCT03947437 -
Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients
|
Phase 1/Phase 2 |